Mr. Steinkrauss is the founder of OWL CFO Consulting, a consulting firm providing part-time CFO services to companies in the biotechnology industry. He previously served as CFO and chief administrative officer of Curis, a publicly traded biotechnology company.
In his new role, Mr. Steinkrauss will lead financial strategy and operations as OcuTerra advances its lead asset for the treatment of diabetic retinopathy, OTT166.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
